Qiagen Story

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:4em;'>QN</div>
QGEN -- USA Stock  

USD 50.75  0.40  0.79%

While this unique economic environment continues, Qiagen NV may throw investors more surprises next month. We will analyze why Qiagen NV investors may still consider a stake in the business. Qiagen NV is at this time traded for 49.45. The entity has historical hype elasticity of 0.23. The average price elasticity to hype of competition is about 0.26. The firm is projected to increase in value after the next headline, with the price going to jump to 49.68. The average volatility of media hype impact on the company stock price is about 133.7%. The price upswing on the next news is estimated to be 0.47%, whereas the daily expected return is at this time at 0.25%. The volatility of related hype on Qiagen NV is about 119.65% with expected price after next announcement by competition of 49.71 Given the investment horizon of 30 days, the next projected press release will be in about 8 days.
Published over a month ago
View all stories for Qiagen NV | View All Stories
Volatility may be your only friend when it comes to investing in Qiagen NV
Our recommendation tool can be used to complement Qiagen NV trade recommendations provided by experts. It analyzes the firm's potential to grow against your specific risk preferences and investment horizon.
The successful prediction of Qiagen NV stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Qiagen NV, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Qiagen NV based on Qiagen NV hews, social hype, general headline patterns, and widely used predictive technical indicators. We also calculate exposure to Qiagen NV's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Qiagen NV's related companies.

Use Technical Analysis to project Qiagen expected Price

Qiagen NV technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Qiagen NV technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Qiagen NV trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions. It is good to see analyst projects for Qiagen NV, but it might be worth checking our own buy vs. sell analysis

What is driving Qiagen NV Investor Appetite?

The company reported the previous year's revenue of 1.61 B. Net Income was 13.89 M with profit before overhead, payroll, taxes, and interest of 1.08 B.

Possible September come-back of Qiagen?

The coefficient of variation is down to 545.74 as of today. Qiagen NV has low volatility with Treynor Ratio of 10.95, Maximum Drawdown of 5.92 and kurtosis of 2.59. However, we advice all investors to further analyze Qiagen NV to make certain all market information is desiminated and is consistent with the current expectations about Qiagen NV upside potential.

Our Conclusion on Qiagen NV

Whereas few other entities within the diagnostics & research industry are still a little expensive, even after the recent corrections, Qiagen NV may offer a potential longer-term growth to institutional investors. To sum up, as of the 16th of August 2020, our analysis shows that Qiagen NV barely shadows the market. The company is overvalued and projects very small odds of financial distress for the next 2 years. However, our ongoing 30 days Buy-Hold-Sell recommendation on the company is Strong Buy.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Gabriel Shpitalnik do not own shares of Qiagen NV. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com